Brett Sandercock, Chief Financial Officer at RESMED INC (RMD), sold 3,000 shares at $270.77 ($812K) on 2025-09-02, disclosed to the SEC on 2025-09-03.
Scheduled sale ($812k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RMD | SELL | 2026-02-03 | $257K | — | Filing → |
| RMD | SELL | 2026-01-05 | $242K | — | Filing → |
| RMD | SELL | 2025-12-02 | $244K | — | Filing → |